(Q80210089)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tobias L Haas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Martin R. Sprick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Geserick P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Drewniok C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Diessenbacher P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Schön MP

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Henkler F

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gollnick H

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Walczak H

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Leverkus M

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

17 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

3211-3220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18084329%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210985

29 December 2019

exact match

0 references

cites work

Is Apaf-1 expression frequently abrogated in melanoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL-receptor antibodies as a potential cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL signalling: decisions between life and death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

c-FLIPR, a new regulator of death receptor-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Toward small-molecule agonists of TNF receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Death receptors and melanoma resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

BH3-only proteins in tumorigenesis and malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

The caspase-8 modulator c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Following a TRAIL: update on a ligand and its five receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

The active caspase-8 heterotetramer is formed at the CD95 DISC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Apoptosis in the treatment of cancer: a promise kept?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

1 reference

7 January 2021

The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Expression and function of the apoptosis effector Apaf-1 in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

The CD95 Receptor: Apoptosis Revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

The role of c-FLIP in modulation of CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

The interplay between the Bcl-2 family and death receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Targeting death-inducing receptors in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021

Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210985

7 January 2021